Contains submitted statement of CRS health care financing analyst Cliff Binder on Medicare Part B prescription drugs and how Medicare reimburses providers for these products, presented before the House Committee on Energy and Commerce Subcom on Health on June 28, 2013.
ProQuest U.S. Congressional Research Digital Collection
Note
CRS Report. Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed May 2014). Reuse except for individual research requires license from ProQuest, LLC.